应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
09995 荣昌生物
未开盘 12-19 16:08:47
15.460
-0.100
-0.64%
最高
15.640
最低
14.980
成交量
85.45万
今开
15.480
昨收
15.560
日振幅
4.24%
总市值
84.15亿
流通市值
29.37亿
总股本
5.44亿
成交额
1,308万
换手率
0.45%
流通股本
1.90亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）
资讯
新帖
简况
南向资金12月18日净买入荣昌生物40.40万股 连续3日增持
市场透视 · 12-19 09:30
南向资金12月18日净买入荣昌生物40.40万股 连续3日增持
12月12日荣昌生物发生1笔大宗交易 成交金额649.19万元
证券之星 · 12-12
12月12日荣昌生物发生1笔大宗交易 成交金额649.19万元
荣昌生物：12月10日召开业绩说明会
证券之星 · 12-10
荣昌生物：12月10日召开业绩说明会
荣昌生物（688331）12月5日主力资金净买入417.22万元
证券之星 · 12-06
荣昌生物（688331）12月5日主力资金净买入417.22万元
荣昌生物（688331）12月4日主力资金净买入236.99万元
证券之星 · 12-05
荣昌生物（688331）12月4日主力资金净买入236.99万元
12月4日荣昌生物跌6.02%，中银创新医疗混合A基金重仓该股
证券之星 · 12-04
12月4日荣昌生物跌6.02%，中银创新医疗混合A基金重仓该股
股市播报｜A股全线下跌，创业板指跌1.34%，近4400只个股下跌
腾讯财经 · 12-04
股市播报｜A股全线下跌，创业板指跌1.34%，近4400只个股下跌
荣昌生物(09995)下跌5.05%，报18.04元/股
金融界 · 12-04
荣昌生物(09995)下跌5.05%，报18.04元/股
荣昌生物盘中异动 早盘股价大跌5.16%
市场透视 · 12-04
荣昌生物盘中异动 早盘股价大跌5.16%
荣昌生物（688331）12月2日主力资金净卖出1577.11万元
证券之星 · 12-03
荣昌生物（688331）12月2日主力资金净卖出1577.11万元
荣昌生物：业绩说明会定于12月10日举行
每日经济新闻 · 12-02
荣昌生物：业绩说明会定于12月10日举行
荣昌生物（688331）11月29日主力资金净卖出154.34万元
证券之星 · 11-30
荣昌生物（688331）11月29日主力资金净卖出154.34万元
荣昌生物：3季度末现金储备11.2亿，如何撑到公司盈利？
公司研究室 · 11-29
荣昌生物：3季度末现金储备11.2亿，如何撑到公司盈利？
荣昌生物（688331）11月28日主力资金净卖出717.37万元
证券之星 · 11-29
荣昌生物（688331）11月28日主力资金净卖出717.37万元
荣昌生物费用管控成效显著，集中资源加速重点管线推进（繁体版）
第一上海 · 11-28
荣昌生物费用管控成效显著，集中资源加速重点管线推进（繁体版）
港股生物医药股午后放量大涨，科伦博泰生物(06990.HK)张近10%，诺诚健华(09969.HK)涨超8.5%，百济神州(06160.
美港电讯 · 11-27
港股生物医药股午后放量大涨，科伦博泰生物(06990.HK)张近10%，诺诚健华(09969.HK)涨超8.5%，百济神州(06160.
异动解读 | 荣昌生物股价大涨5.05%,创新药RC-18临床进展利好公司业绩
异动解读 · 11-27
异动解读 | 荣昌生物股价大涨5.05%,创新药RC-18临床进展利好公司业绩
荣昌生物盘中异动 下午盘快速上涨5.05%
市场透视 · 11-27
荣昌生物盘中异动 下午盘快速上涨5.05%
诺华IgA肾病新药在中国申报上市！国内入局者包括云顶新耀、荣昌生物、恒瑞医药等
中国制药网 · 11-27
诺华IgA肾病新药在中国申报上市！国内入局者包括云顶新耀、荣昌生物、恒瑞医药等
港股异动 | 荣昌生物(09995)涨超3% RC18SLE适应症于今年起执行新医保价格
智通财经 · 11-27
港股异动 | 荣昌生物(09995)涨超3% RC18SLE适应症于今年起执行新医保价格
加载更多
公司概况
公司名称：
荣昌生物
所属市场：
SEHK
上市日期：
--
主营业务：
荣昌生物制药（烟台）股份有限公司是一家主要从事创新型生物药研发和制造的中国公司。该公司专注于抗体药物偶联物（ADC）、抗体融合蛋白、单克隆抗体及双特异性抗体等治疗性抗体药物的发现、开发与商业化。该公司的主要产品包括泰它西普（RC18）、维迪西妥单抗（RC48）和双靶点融合蛋白（RC28）。该公司的产品主要应用于治疗自身免疫疾病、肿瘤和眼科等重大疾病。该公司主要在国内市场开展业务。
发行价格：
--
{"stockData":{"symbol":"09995","market":"HK","secType":"STK","nameCN":"荣昌生物","latestPrice":15.46,"timestamp":1734595727019,"preClose":15.56,"halted":0,"volume":854500,"delay":0,"floatShares":190000000,"shares":544332083,"eps":-3.0036173,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.1,"latestTime":"12-19 16:08:47","open":15.48,"high":15.64,"low":14.98,"amount":13076380,"amplitude":0.042416,"askPrice":15.52,"askSize":1500,"bidPrice":15.44,"bidSize":2500,"shortable":3,"etf":0,"ttmEps":-3.0898061622991864,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734658200000},"adr":0,"listingDate":1604851200000,"adjPreClose":15.56,"openAndCloseTimeList":[[1734571800000,1734580800000],[1734584400000,1734595200000]],"volumeRatio":0.800243,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688331","market":"SH","secType":"STK","nameCN":"荣昌生物","latestPrice":32.85,"timestamp":1734591600000,"preClose":32.94,"halted":0,"volume":1489563,"delay":0,"premium":"-56.13"}},"requestUrl":"/m/hq/s/09995","defaultTab":"news","newsList":[{"id":"2492193394","title":"南向资金12月18日净买入荣昌生物40.40万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2492193394","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492193394?lang=zh_cn&edition=full","pubTime":"2024-12-19 09:30","pubTimestamp":1734571825,"startTime":"0","endTime":"0","summary":"12月18日, 南向资金增持荣昌生物40.40万股，连续3日增持。截止当日收盘，港股通共持有荣昌生物6907.72万股，占流通股36.42%。港股通增持金额前五个股分别为中国移动、工商银行、建设银行、中国海洋石油、中国平安。荣昌生物近5个交易日下跌8.36%，港股通累计增持39.60万股；近20个交易日下跌14.13%，港股通累计增持270.66万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219093824a1f9e22c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219093824a1f9e22c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","LU2328871848.SGD","LU1969619763.USD","BK1161","09995","688331","BK1574"],"gpt_icon":0},{"id":"2490773318","title":"12月12日荣昌生物发生1笔大宗交易 成交金额649.19万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490773318","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490773318?lang=zh_cn&edition=full","pubTime":"2024-12-12 17:20","pubTimestamp":1733995225,"startTime":"0","endTime":"0","summary":"证券之星消息，12月12日荣昌生物发生大宗交易，交易数据如下：大宗交易成交价格35.89元，成交18.09万股，成交金额649.19万元，买方营业部为中信证券股份有限公司深圳深南中路中信大厦证券营业部，卖方营业部为国泰君安证券股份有限公司总部。近三个月该股共发生1笔大宗交易，合计成交1809.0手。截至2024年12月12日收盘，荣昌生物报收于35.89元，上涨2.48%，换手率1.97%，成交量3.19万手，成交额1.14亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121200027965.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","LU2328871848.SGD","09995","BK1583","LU1969619763.USD","BK0239","688331","BK1574","LU2148510915.USD","LU1064130708.USD","LU1064131003.USD"],"gpt_icon":0},{"id":"2490095729","title":"荣昌生物：12月10日召开业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2490095729","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490095729?lang=zh_cn&edition=full","pubTime":"2024-12-10 19:03","pubTimestamp":1733828632,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年12月10日荣昌生物发布公告称公司于2024年12月10日召开业绩说明会。荣昌生物2024年三季报显示，公司主营收入12.09亿元，同比上升57.1%；归母净利润-10.71亿元，同比下降3.96%；扣非净利润-10.97亿元，同比下降3.45%；其中2024年第三季度，公司单季度主营收入4.67亿元，同比上升34.6%；单季度归母净利润-2.91亿元，同比上升11.08%；单季度扣非净利润-3.04亿元，同比上升8.81%；负债率58.54%，投资收益124.19万元，财务费用4949.75万元，毛利率79.75%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121000036097.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1064131003.USD","BK1574","688331","LU2148510915.USD","BK0239","BK1161","LU1969619763.USD","LU1064130708.USD","09995","LU2328871848.SGD","BK1583"],"gpt_icon":0},{"id":"2489499914","title":"荣昌生物（688331）12月5日主力资金净买入417.22万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489499914","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489499914?lang=zh_cn&edition=full","pubTime":"2024-12-06 08:25","pubTimestamp":1733444753,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年12月5日收盘，荣昌生物报收于36.68元，下跌1.27%，换手率1.96%，成交量3.17万手，成交额1.17亿元。近5日资金流向一览见下表：荣昌生物融资融券信息显示，融资方面，当日融资买入802.56万元，融资偿还469.4万元，融资净买入333.16万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120600007432.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09995","BK1161","LU2148510915.USD","BK0239","LU1064131003.USD","LU2328871848.SGD","688331","LU1064130708.USD","LU1969619763.USD","BK1574","BK1583"],"gpt_icon":0},{"id":"2489178357","title":"荣昌生物（688331）12月4日主力资金净买入236.99万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489178357","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489178357?lang=zh_cn&edition=full","pubTime":"2024-12-05 08:20","pubTimestamp":1733358044,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年12月4日收盘，荣昌生物报收于37.15元，下跌6.02%，换手率2.67%，成交量4.33万手，成交额1.64亿元。近5日资金流向一览见下表：荣昌生物融资融券信息显示，融资方面，当日融资买入1378.42万元，融资偿还1010.24万元，融资净买入368.18万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120500007027.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1969619763.USD","LU1064130708.USD","BK1574","BK0239","09995","LU2328871848.SGD","688331","BK1583","LU1064131003.USD","LU2148510915.USD","BK1161"],"gpt_icon":0},{"id":"2488156117","title":"12月4日荣昌生物跌6.02%，中银创新医疗混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2488156117","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488156117?lang=zh_cn&edition=full","pubTime":"2024-12-04 16:08","pubTimestamp":1733299721,"startTime":"0","endTime":"0","summary":"证券之星消息，12月4日荣昌生物跌6.02%，收盘报37.15元，换手率2.67%，成交量4.33万手，成交额1.64亿元。根据2024基金Q3季报公募基金重仓股数据，重仓该股的公募基金共21家，其中持有数量最多的公募基金为中银创新医疗混合A。中银创新医疗混合A目前规模为21.23亿元，最新净值1.3839，较上一交易日上涨0.39%，近一年下跌5.35%。中银创新医疗混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120400027503.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","LU1064130708.USD","BK0114","BK0236","BK0239","BK0077","LU2328871848.SGD","002173","LU1969619763.USD","BK1161","09995","688331","LU2148510915.USD","BK1574","BK0096","LU1064131003.USD"],"gpt_icon":0},{"id":"2488134068","title":"股市播报｜A股全线下跌，创业板指跌1.34%，近4400只个股下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2488134068","media":"腾讯财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488134068?lang=zh_cn&edition=full","pubTime":"2024-12-04 14:39","pubTimestamp":1733294367,"startTime":"0","endTime":"0","summary":"09:00 富时中国A50指数期货开跌0.2% 富时中国A50指数期货在上一交易日夜盘收跌0.16%的基础上低开，现跌0.2%。 ","market":"us","thumbnail":"https://inews.gtimg.com/news_ls/OS2OZ4kVzxwLdMtjz_jdA3In4qTAeMU9kR0cj2d-trFY4AA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/news_ls/OS2OZ4kVzxwLdMtjz_jdA3In4qTAeMU9kR0cj2d-trFY4AA_294195/0"],"rights":{"source":"tencent_tech","url":"https://view.inews.qq.com/a/20241204A01MIJ00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://view.inews.qq.com/a/20241204A01MIJ00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["BK4506","LU1969619763.USD","LU0307460666.USD","LU0039217434.USD","LU1794554557.SGD","IE00BPRC5H50.USD","HHImain","HSCEI","LU0588546209.SGD","LU2488822045.USD","BK1519","SG9999006597.SGD","09995","BK1163","HSI","HSTECH","LU0370786039.SGD","02105","LU0502904849.HKD","MCHmain","01541","IE00B5MMRT66.SGD","LU0052750758.USD","LU0572944931.SGD","YANG","BK1526","LU0048580855.USD","IE0034224299.USD","BK1583","EDU","LU0320764599.SGD","LU0348783233.USD","LU0348784397.USD","LU0708995583.HKD","BK1589","BK4505","LU1720050803.USD","513600","01347","09901","BK1574","LU0823426480.USD","LU2242644610.SGD","09926","BK4510","09660","BK1109","02833"],"gpt_icon":1},{"id":"2488242188","title":"荣昌生物(09995)下跌5.05%，报18.04元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2488242188","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488242188?lang=zh_cn&edition=full","pubTime":"2024-12-04 09:48","pubTimestamp":1733276893,"startTime":"0","endTime":"0","summary":"12月4日，荣昌生物(09995)盘中下跌5.05%，截至09:48，报18.04元/股，成交496.33万元。荣昌生物制药(烟台)股份有限公司的主营业务是发现、开发、生产和商业化同类首创、同类最佳的生物药物，主要针对自身免疫、肿瘤、眼科等重大疾病领域。公司在中国和美国设有实验研究机构和办事处，已创制出一批具有重大临床价值的生物新药。截至2024年三季报，荣昌生物营业总收入12.09亿元、净利润-10.71亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/04094845987207.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1583","BK1574","09995","BK0239","LU1064130708.USD","LU1064131003.USD","LU2148510915.USD","BK1161","LU1969619763.USD","LU2328871848.SGD","688331"],"gpt_icon":0},{"id":"2488007769","title":"荣昌生物盘中异动 早盘股价大跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488007769","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488007769?lang=zh_cn&edition=full","pubTime":"2024-12-04 09:48","pubTimestamp":1733276890,"startTime":"0","endTime":"0","summary":"2024年12月04日早盘09时48分，荣昌生物股票出现异动，股价快速跳水5.16%。截至发稿，该股报18.020港元/股，成交量27万股，换手率0.14%，振幅3.89%。机构评级方面，在所有20家参与评级的机构中，85%的券商给予买入建议，15%的券商给予持有建议，无券商给予卖出建议。荣昌生物股票所在的生物技术行业中，整体跌幅为0.37%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204094810abf43228&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204094810abf43228&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","LU1969619763.USD","09995","LU2328871848.SGD","BK1583"],"gpt_icon":0},{"id":"2488938078","title":"荣昌生物（688331）12月2日主力资金净卖出1577.11万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488938078","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488938078?lang=zh_cn&edition=full","pubTime":"2024-12-03 08:17","pubTimestamp":1733185042,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年12月2日收盘，荣昌生物报收于37.68元，上涨5.02%，换手率3.43%，成交量5.56万手，成交额2.06亿元。近5日资金流向一览见下表：荣昌生物融资融券信息显示，融资方面，当日融资买入1025.04万元，融资偿还1228.72万元，融资净偿还203.68万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120300008000.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1969619763.USD","688331","LU2148510915.USD","BK1574","BK1583","LU2328871848.SGD","LU1064130708.USD","BK1161","09995","BK0239","LU1064131003.USD"],"gpt_icon":0},{"id":"2488262130","title":"荣昌生物：业绩说明会定于12月10日举行","url":"https://stock-news.laohu8.com/highlight/detail?id=2488262130","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488262130?lang=zh_cn&edition=full","pubTime":"2024-12-02 17:44","pubTimestamp":1733132694,"startTime":"0","endTime":"0","summary":"每经AI快讯，荣昌生物12月2日晚间发布公告称，公司2024年第三季度业绩说明会定于2024年12月10日上午10:00-11:00，以上证路演中心网络互动的形式进行。出席本次业绩说明会的人员有：董事长王威东，总经理房健民，董事会秘书温庆凯，首席财务官兼联席公司秘书童少靖，独立董事陈云金。荣昌生物的董事长是王威东，男，65岁，学历背景为本科。每经头条（nbdtoutiao）——任务完不成，每周扣1000元！有银行客户经理吐槽“大家都等着降级”！有人一个季度绩效1万元，他说：工作压力很大(记者 蔡鼎)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202174500a265f35f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202174500a265f35f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1969619763.USD","688331","BK1574","BK1583","LU2328871848.SGD","BK1161","09995"],"gpt_icon":0},{"id":"2487123105","title":"荣昌生物（688331）11月29日主力资金净卖出154.34万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2487123105","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487123105?lang=zh_cn&edition=full","pubTime":"2024-11-30 08:24","pubTimestamp":1732926285,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年11月29日收盘，荣昌生物报收于35.88元，下跌0.36%，换手率2.98%，成交量4.83万手，成交额1.74亿元。近5日资金流向一览见下表：荣昌生物融资融券信息显示，融资方面，当日融资买入884.41万元，融资偿还988.1万元，融资净偿还103.69万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024113000008244.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09995","LU2148510915.USD","LU1969619763.USD","LU1064130708.USD","BK1161","BK1583","LU2328871848.SGD","BK1574","LU1064131003.USD","BK0239","688331"],"gpt_icon":0},{"id":"2487560107","title":"荣昌生物：3季度末现金储备11.2亿，如何撑到公司盈利？","url":"https://stock-news.laohu8.com/highlight/detail?id=2487560107","media":"公司研究室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487560107?lang=zh_cn&edition=full","pubTime":"2024-11-29 12:45","pubTimestamp":1732855557,"startTime":"0","endTime":"0","summary":"出品/公司研究室上市公司组文/淮上月近日，科创板生物制药公司荣昌生物（688331.SH）发布了一份2024年10月30日-11月6日投资者关系活动记录表。记录表显示，参加活动的机构累计上百家。记录内容就两个：一是2024Q3 财务概况；二是2024Q3 核心管线开发进展。这些内容与荣昌生物对公司研究室沟通函的回复口径基本一致。不过，...","market":"us","thumbnail":"https://inews.gtimg.com/om_ls/OyTV7MHgrz_rvXMihni1EeB3rtBXk5UHmy8LhHQ9sAM04AA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OyTV7MHgrz_rvXMihni1EeB3rtBXk5UHmy8LhHQ9sAM04AA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241129A04A1W00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241129A04A1W00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["LU2328871848.SGD","09995","BK1583","BK1161","BK1574","LU1969619763.USD"],"gpt_icon":0},{"id":"2487378659","title":"荣昌生物（688331）11月28日主力资金净卖出717.37万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2487378659","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487378659?lang=zh_cn&edition=full","pubTime":"2024-11-29 08:20","pubTimestamp":1732839658,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年11月28日收盘，荣昌生物报收于36.01元，下跌2.78%，换手率2.87%，成交量4.65万手，成交额1.71亿元。近5日资金流向一览见下表：荣昌生物融资融券信息显示，融资方面，当日融资买入929.33万元，融资偿还1052.5万元，融资净偿还123.17万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112900005020.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1064130708.USD","688331","BK1583","09995","BK1161","LU2148510915.USD","LU1064131003.USD","LU2328871848.SGD","BK0239","BK1574","LU1969619763.USD"],"gpt_icon":0},{"id":"2486601351","title":"荣昌生物费用管控成效显著，集中资源加速重点管线推进（繁体版）","url":"https://stock-news.laohu8.com/highlight/detail?id=2486601351","media":"第一上海","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486601351?lang=zh_cn&edition=full","pubTime":"2024-11-28 13:13","pubTimestamp":1732770818,"startTime":"0","endTime":"0","summary":"公司Q3销售费用率49.9%，连续两个季度维持在50%以下。研发费用环比下降26.9%，费用率74.3%。截止9月30日，公司在手现金及现金等价物11.2亿元，贷款授信额度28亿元。BC伴肝转移适应症已递交上市申请并纳入优先审评，有望在2025年获批。研发控费集中资源，重点管线持续推进：在公司梳理临床管线后，重点管线也将获得更多资源以加速推进。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128133032a25b85c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128133032a25b85c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09995","BK1574","LU1969619763.USD","LU2328871848.SGD","BK1161","BK1583"],"gpt_icon":0},{"id":"2486131668","title":"港股生物医药股午后放量大涨，科伦博泰生物(06990.HK)张近10%，诺诚健华(09969.HK)涨超8.5%，百济神州(06160.","url":"https://stock-news.laohu8.com/highlight/detail?id=2486131668","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486131668?lang=zh_cn&edition=full","pubTime":"2024-11-27 15:16","pubTimestamp":1732691817,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1583","HSTECH","YANG","03347","BGNE","BK4548","HSCEI","BK1576","LU0588546209.SGD","BK0216","09969","BK4588","LU1146622755.USD","LU1969619763.USD","LU1064131003.USD","09995","BK1161","688428","LU0307460666.USD","BK0028","161726","BK0239","BK4139","BK0174","688331","300347","SG9999014674.SGD","LU1064130708.USD","BK0077","688235","399441","BK1574","BK1588","BK4505","07226","LU2148510915.USD","BK4585","LU2328871848.SGD","02268","BK1141","BK4504","BK4535","BK4526","06160","LU0196878994.USD","LU1820825898.SGD","BK1500","06990"],"gpt_icon":0},{"id":"1123757695","title":"异动解读 | 荣昌生物股价大涨5.05%,创新药RC-18临床进展利好公司业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1123757695","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123757695?lang=zh_cn&edition=full","pubTime":"2024-11-27 15:06","pubTimestamp":1732691203,"startTime":"0","endTime":"0","summary":"荣昌生物今日盘中大涨5.05%,引发市场关注。消息面上,该股价上涨主要受到以下几方面利好因素的驱动:. 首先,荣昌生物研发的治疗IgA肾病创新药物RC-18正处于关键的临床III期阶段。公司表示,将与监管部门保持沟通,争取尽早申报该新适应症。市场预计荣昌生物有望在明年实现扭亏为盈,长期增长前景受到资金青睐。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["09995"],"gpt_icon":0},{"id":"2486406815","title":"荣昌生物盘中异动 下午盘快速上涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486406815","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486406815?lang=zh_cn&edition=full","pubTime":"2024-11-27 15:05","pubTimestamp":1732691121,"startTime":"0","endTime":"0","summary":"2024年11月27日下午盘15时05分，荣昌生物股票出现波动，股价急速上涨5.05%。截至发稿，该股报17.880港元/股，成交量199.05万股，换手率1.05%，振幅6.46%。荣昌生物股票所在的生物技术行业中，整体涨幅为2.36%。荣昌生物公司简介：研发、生产和销售医药产品、诊断试剂产品,以及进行与上述产品及其研发相关的技术服务、技术转让,货物或技术进出口。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112715052198e44db2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112715052198e44db2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09995","BK1574","LU2328871848.SGD","LU1969619763.USD","BK1583"],"gpt_icon":0},{"id":"2486909958","title":"诺华IgA肾病新药在中国申报上市！国内入局者包括云顶新耀、荣昌生物、恒瑞医药等","url":"https://stock-news.laohu8.com/highlight/detail?id=2486909958","media":"中国制药网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486909958?lang=zh_cn&edition=full","pubTime":"2024-11-27 14:10","pubTimestamp":1732687848,"startTime":"0","endTime":"0","summary":"IgA肾病是一种常见的原发性肾小球疾病，对药物需求巨大。今年11月8日荣昌生物在投资者互动平台上表示，泰它西普用于IgA肾病的Ⅲ期临床入组已完成，目前正在用药随访中，公司将与CDE保持沟通，争取尽早实现新适应症申报。今年5月， 恒瑞医药 的1类新药SHR-2173注射液获得临床试验默示许可，适应症为IgA肾病。此外，国内布局IgA肾病药物的企业还包括智康弘仁、 翰森制药 、星浩澎博、 海 思科 等等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127143655abe27ba0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127143655abe27ba0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688331","600276","LU2148510915.USD","BK0012","01952","BK0183","LU1064130708.USD","BK0188","BK0060","LU1328615791.USD","LU2488822045.USD","LU0405327148.USD","BK0196","BK0028","LU0405327494.USD","09995","BK0239","LU1064131003.USD"],"gpt_icon":0},{"id":"2486675118","title":"港股异动 | 荣昌生物(09995)涨超3% RC18SLE适应症于今年起执行新医保价格","url":"https://stock-news.laohu8.com/highlight/detail?id=2486675118","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486675118?lang=zh_cn&edition=full","pubTime":"2024-11-27 11:13","pubTimestamp":1732677225,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，荣昌生物涨超3%，截至发稿，涨2.59%，报17.46港元，成交额1798.13万港元。3Q24公司实现营收4.67亿元，yoy+34.60%，年初至今累计实现收入12.09亿元，yoy+57.10%。收入的增长主要系核心产品RC18、RC48的持续放量，其中RC18SLE适应症于今年起执行新的医保价格，RA适应症于今年7月份获批上市，预计快速贡献增量。该行续指，3Q24公司净亏损2.91亿元，单季度亏损为4Q22以来最低。截至9月30日，公司拥有11.2亿元现金储备。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1216431.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1064131003.USD","688331","LU1064130708.USD","BK1574","BK0239","LU2328871848.SGD","LU1969619763.USD","09995","BK1583","LU2148510915.USD","BK1161"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0809},{"period":"1month","weight":-0.0515},{"period":"3month","weight":0.4422},{"period":"6month","weight":-0.4099},{"period":"1year","weight":-0.544},{"period":"ytd","weight":-0.5872}],"compareEarnings":[{"period":"1week","weight":-0.0316},{"period":"1month","weight":0.0045},{"period":"3month","weight":0.0818},{"period":"6month","weight":0.0956},{"period":"1year","weight":0.1889},{"period":"ytd","weight":0.1587}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"荣昌生物制药（烟台）股份有限公司是一家主要从事创新型生物药研发和制造的中国公司。该公司专注于抗体药物偶联物（ADC）、抗体融合蛋白、单克隆抗体及双特异性抗体等治疗性抗体药物的发现、开发与商业化。该公司的主要产品包括泰它西普（RC18）、维迪西妥单抗（RC48）和双靶点融合蛋白（RC28）。该公司的产品主要应用于治疗自身免疫疾病、肿瘤和眼科等重大疾病。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.188174},{"month":2,"riseRate":0.75,"avgChangeRate":0.173193},{"month":3,"riseRate":0.25,"avgChangeRate":-0.108046},{"month":4,"riseRate":0.75,"avgChangeRate":-0.020996},{"month":5,"riseRate":0.25,"avgChangeRate":-0.095931},{"month":6,"riseRate":0.75,"avgChangeRate":0.127279},{"month":7,"riseRate":0.5,"avgChangeRate":-0.067258},{"month":8,"riseRate":0.25,"avgChangeRate":-0.07116},{"month":9,"riseRate":0.5,"avgChangeRate":0.075505},{"month":10,"riseRate":0.5,"avgChangeRate":0.092826},{"month":11,"riseRate":1,"avgChangeRate":0.04024},{"month":12,"riseRate":0.4,"avgChangeRate":-0.007146}],"exchange":"SEHK","name":"荣昌生物","nameEN":"REMEGEN"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"荣昌生物(09995)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供荣昌生物(09995)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"荣昌生物,09995,荣昌生物股票,荣昌生物股票老虎,荣昌生物股票老虎国际,荣昌生物行情,荣昌生物股票行情,荣昌生物股价,荣昌生物股市,荣昌生物股票价格,荣昌生物股票交易,荣昌生物股票购买,荣昌生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"荣昌生物(09995)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供荣昌生物(09995)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}